Indianapolis Business Journal

Retirement plans are treading cautiously into cryptocurrency; many employers aren’t taking the leap at all

Worries about the volatility of digital currencies and a plan-sponsor’s duty to protect its participants are among the ...
Finanznachrichten

Novartis Pharma AG: Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring importance of early ...